Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL615052 Target Snapshot

Mycobacterium tuberculosis variant bovis BCG · ORGANISM · Mycobacterium tuberculosis variant bovis BCG

1,187Compounds
124Assays
1Approved Drugs
96.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mycobacterium tuberculosis variant bovis BCG as ChEMBL target CHEMBL615052. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mycobacterium tuberculosis variant bovis BCG
ORGANISM · Mycobacterium tuberculosis variant bovis BCG
As of 2026-09-13
ChEMBL target ID
CHEMBL615052
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mycobacterium tuberculosis variant bovis BCG still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMycobacterium tuberculosis variant bovis BCG
UniProt AccessionN/A

Mycobacterium tuberculosis variant bovis BCG

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mycobacterium tuberculosis variant bovis BCG.

Review nameMycobacterium tuberculosis variant bovis BCG
OrganismMycobacterium tuberculosis variant bovis BCG
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5096.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL32 7.52 IC50 30.0 Approved
CHEMBL4521723 5.3 IC50 5030.0 Preclinical
CHEMBL4455926 5.1 IC50 7900.0 Preclinical
CHEMBL4458310 4.99 IC50 10350.0 Preclinical
CHEMBL4443260 4.9 IC50 12530.0 Preclinical
CHEMBL4456278 4.83 IC50 14950.0 Preclinical
CHEMBL4561092 4.76 IC50 17390.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
0
5.5
0
6.0
0
6.5
0
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MOXIFLOXACIN
CHEMBL32
Approved 1999
Assay Landscape

Assay Landscape

125
Total Assays
7
Tested Compounds
1
Assay Types
Functional — 125 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 122 7 5.3
assay format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine